Figure 3From: MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer Dose distributions for the following plans: conformal external beam plans where dose is relative to the prescription dose to the target (A); the HDR brachytherapy plan where the 100% isodose corresponds to 10Gy (B) and the SIB HDR brachytherapy plan where the 100% isodose corresponds to 7.5Gy (C).Back to article page